Somer Baburek currently serves as the President & CEO of Hera Biotech, a women’s health company focused on commercializing a non-surgical diagnostic for early detection of endometriosis. Before founding Hera, Somer spent ten years in life science venture capital at Targeted Technology Fund, the largest life science fund in San Antonio. During her time with Targeted Tech, she also served as the Director of Clinical Operations for Santalis Pharmaceuticals where she built out the clinical program at the company over seven years. During her tenure, Santalis expanded its clinical program from a single IND to four active INDs; and from 2 domestic clinical trials to over 10 clinical trials, including 2 international trials. Somer earned her MBA with a specialization in Data Analytics, from Louisiana State University, and prior to her work with the Targeted Technology Fund and Santalis, Somer attended the University of Texas San Antonio where she graduated Magna Cum Laude with a degree in entrepreneurship and was the winner of the prestigious C.I.T.E. (Center for Innovation Technology and Entrepreneurship) annual student competition, with a women’s health technology she invented.